| | | | | |
| €27.0332 | -0.93 % | €240.31M | €12.59K | |
DBL DOUBLELINE OPPORTUNISTIC CREDIT FUND | €12.1214 | +0.63 % | €240.01M | €36.85K | |
TSI TCW Strategic Income Fund, Inc. | €3.7652 | +0.34 % | €239.62M | €91.34K | |
PAII Pyrophyte Acquisition Corp. II | €8.8112 | +0.15 % | €239.20M | €5.996 | |
| €12.2722 | +2.32 % | €239.08M | €99.03K | |
YDES YD Bio Limited Ordinary Shares | €3.7018 | -7.27 % | €239.08M | €4.65K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8.6056 | +0.55 % | €238.77M | €5.11K | |
RWAY Runway Growth Finance Corp. Common Stock | €5.6242 | -0.08 % | €238.76M | €104.48K | |
JILL J.Jill, Inc. Common Stock | €16.8718 | -1.58 % | €238.75M | €6.03K | |
LCTX Lineage Cell Therapeutics, Inc. | €0.93809 | +0.46 % | €238.33M | €249.90K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8.8403 | -0.01 % | €238.26M | €130.77K | |
ACV Virtus Diversified Income & Convertible Fund | €22.7497 | +0.36 % | €238.24M | €21.74K | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1.7434 | +2.26 % | €238.10M | €193.28K | |
| €1.2294 | +2.50 % | €238.02M | €261.92K | |
YSG Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares | €2.5658 | -0.17 % | €237.87M | €18.79K | |
